SBIR/STTR Reauthorized Through 2031: What S. 3971 Changes for Applicants, Commercialization, and University IP Strategy On April 13, 2026, the White House announced that S. 3971, the Small Business Innovation
As of March 11, 2026, the Small Business Innovation and Economic Security Act (S. 3971) is poised for House floor consideration, following a bipartisan compromise and Senate approval. This pivotal
Are you a small business looking to innovate in the biomedical field? The NIH’s SBIR program offers exciting funding opportunities tailored to your research goals. With options like Sequential Submission,
Assembling an SBIR/STTR grant application is a process with countless details, but here are a few strategic steps to enhance your proposal. These guides are specific for NIH applications, but
In today’s competitive funding landscape, crafting a successful grant proposal demands more than just good science. It requires a clear narrative, alignment with agency priorities, and the ability to persuade
If you’re a startup founder or small business relying on SBIR/STTR for your R&D, the recent disruptions have been significant. With Congress allowing SBIR/STTR’s authority to expire, agencies are unable
Artificial intelligence is revolutionizing grant writing, transforming how research teams develop proposals. In 2026, the focus has shifted from whether to use AI to how to harness its capabilities responsibly.
Unlock the potential of Other Sponsored Support (OSC) funding from the Department of Defense (DoD) to elevate your research and technical capabilities. Unlike traditional grants, OSC mechanisms offer flexibility and
In 2026, early-stage technology companies face a critical decision: pursue SBIR funding or seek venture capital? Each path offers unique advantages and challenges that can shape a startup’s trajectory. SBIR
Are you curious about how universities can tap into innovative funding pathways? The Other Transaction Authority (OTA) is transforming the landscape of federal funding, offering a flexible alternative to traditional
For decades, NIH and NSF have been the backbone of university research funding. However, in an era of budget uncertainty and shifting federal priorities, relying solely on these agencies poses
As conversations about potential 2026 budget reductions circulate in Washington, the research community faces a pressing question: what happens if federal funding is cut? Even modest reductions can create ripple
For many principal investigators, the R01 remains the benchmark of independent research funding. However, a pressing question lingers: are NIH R01 paylines getting harder? The answer is nuanced, influenced by
NIH R37 MERIT (Method to Extend Research in Time) Award The NIH R37 MERIT Award (Method to Extend Research in Time) is designed to provide long-term, stable support to investigators
International research funding is a vital component of the global innovation ecosystem, yet navigating its complexities can be challenging. As U.S. scientists face increasing regulatory constraints and eligibility hurdles, understanding
As artificial intelligence becomes increasingly integrated into academic workflows, universities are exploring the potential of internal AI grant writing tools. These systems could alleviate the administrative burden on faculty by
Every NIH applicant knows the importance of scoring criteria like Significance, Innovation, and Approach. Yet, many strong proposals still fall short of the payline. Why? The answer lies in a
When researchers think about funding, federal agencies typically dominate the conversation. However, private foundations distribute billions annually across various fields, offering a unique opportunity for scientists. Unlike federal mechanisms, foundations
In the high-stakes world of life sciences, every moment counts. Regulatory submissions like INDs, NDAs, and PMAs are not mere formalities; they are critical documents that demand scientific rigor and
Regulatory Writing Series #1: What Is Regulatory Writing? A Clear Guide for Startups and Research Teams by Charles Replogle, COO of ScienceDocs 14 March 2025 If your startup or research team
Unlocking funding opportunities can be a game-changer for small businesses, especially through the SBIR/STTR program. This vital source of non-dilutive funding can be amplified with state matching programs, providing even
Maximizing Direct Costs Under the Threatened NIH 15% Indirect Cap by Charles Replogle, COO of ScienceDocs 9 February 2025 The recent announcement capping NIH indirect costs at 15% has left
Navigating the NIH’s Threatened Indirect Cost Cap: Strategies for Academic Researchers by Charles Replogle, COO of ScienceDocs 8 February 2025 I almost hope this topical blog post doesn’t age well,
Recognize common mistakes in the NIH Specific Aims section of your grant proposal by Dr. Long, 11/18/24 The NIH funds many kinds of grants, yet most have a 1-page